Insigneo Advisory Services’s BeOne Medicines ONC Stock Holding History
Bought
Maintained
Sold
Other funds holding ONC
BBA
Insigneo Advisory Services's ONC Position: Q3 2026 in Review
Insigneo Advisory Services reduced its BeOne Medicines (ONC) stake by 17% in Q3 2026, selling an estimated $57.1K and leaving 843 shares worth $308K. The position accounts for 0.01% of the portfolio, ranked #630.
Insigneo Advisory Services first reported a position in ONC in Q2 2026 and has held it in 2 quarters since. 318 funds tracked by Wall St. Rank hold ONC as of Q3 2026.
- Insigneo Advisory Services held 843 shares of BeOne Medicines worth $308K as of Q3 2026.
- Insigneo Advisory Services sold 167 BeOne Medicines shares in Q3 2026, an estimated $57.1K.
- BeOne Medicines made up 0.01% of Insigneo Advisory Services's portfolio in Q3 2026, its #630 holding.
- Insigneo Advisory Services first reported a position in BeOne Medicines in Q2 2026 and has held it in 2 quarters since.
- 318 funds tracked by Wall St. Rank held BeOne Medicines as of Q3 2026.
Based on Insigneo Advisory Services's 13F filing for Q3 2026, filed 13 Nov 2026.